IDO1 and neoplasm: This suggests that IL-10RA could serve as an alternative target for efficiently modulating immunity through the regulation of IL-10 signalling and IDO expression, particularly relieving the immune-suppressive interaction of tumour cells/stromal cells and cytotoxic T cells with TME.